Related Experiment Video
Updated: Jul 28, 2026

Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
Published on: June 29, 2016
Association of low levels of mannan-binding protein with a common defect of opsonisation
Abstract:
Failure to opsonise bakers' yeast (Saccharomyces cerevisiae) is a defect found in 5-7% of the general population. In this study, the presence of the defect was linked with low levels of mannan-binding protein (MBP), a calcium-dependent serum lectin. Purified MBP corrected the defect in a dose-dependent way in an in-vitro assay measuring the deposition of complement moieties on a mannan-coated surface. There was a highly significant correlation between the serum MBP level and the generation of C3b opsonins in a population of healthy blood donors. The median MBP level of ten children previously shown to have the functional opsonic defect was 4.9 micrograms/l (range 2.5-35.0 micrograms/l) compared with 143 micrograms/l (range 2.5-880 micrograms/l) for a paediatric control group.
Insights
A common defect in yeast opsonisation is linked to low mannan-binding protein (MBP) levels. Supplementing MBP corrected this defect, highlighting its crucial role in the immune response.
Area of Science:
- Immunology
- Microbiology
Background:
- 5-7% of the population exhibits a defect in opsonising Saccharomyces cerevisiae (baker's yeast).
- This defect is associated with reduced levels of mannan-binding protein (MBP), a calcium-dependent serum lectin.
Purpose of the Study:
- To investigate the link between low mannan-binding protein (MBP) levels and the defect in yeast opsonisation.
- To determine if purified MBP can correct the opsonic defect in vitro.
Main Methods:
- An in-vitro assay was used to measure complement moiety deposition on a mannan-coated surface.
- Serum MBP levels were measured and correlated with C3b opsonin generation in healthy blood donors.
- MBP levels were compared between children with the opsonic defect and a paediatric control group.
Main Results:
- Purified MBP corrected the yeast opsonisation defect in a dose-dependent manner.
- A significant correlation was found between serum MBP levels and C3b opsonin generation.
- Children with the opsonic defect had significantly lower median MBP levels (4.9 µg/l) compared to controls (143 µg/l).
Conclusions:
- Low serum mannan-binding protein (MBP) levels are directly linked to the common defect in Saccharomyces cerevisiae opsonisation.
- MBP plays a critical role in complement-mediated opsonisation and innate immunity.
- MBP supplementation is a potential therapeutic strategy for individuals with this opsonic defect.
Related Concept Videos
Humoral Immune Responses
Oligosaccharide Assembly
Multiple sugar molecules that may or may...
Proteoglycans
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Complement System

